NT-proBNP Levels Following IVIG Treatment of Multisystem Inflammatory Syndrome in Children | Citedby Results | Hospital Pediatrics | American Academy of Pediatrics

Skip to Main Content

Skip Nav Destination

NT-proBNP Levels Following IVIG Treatment of Multisystem Inflammatory Syndrome in Children

Hosp Pediatr (2022) 12 (7): e261–e265.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Clinical Predictors of Subacute Myocardial Dysfunction in Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19

Daniel McAree
Amanda Hauck
Jennifer Arzu
Michael Carr
Jennifer Acevedo
Ami B. Patel
Nazia Husain

Pediatric Cardiology (2022)

Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19

Diego Estrada-Luna
Elizabeth Carreón-Torres
Susana González-Reyes
María Fernanda Martínez-Salazar
María Araceli Ortiz-Rodríguez
Esther Ramírez-Moreno
José Arias-Rico
Angélica Saraí Jiménez-Osorio

Life (2022) 12 (10): 1652.